arrow
M

María U. Moreno

university of navarra
H指数:28
被引数:3,454

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial

基于生物标志物的胶原交联评估确定有心力衰竭风险的患者更有可能受益于螺内酯对左心房重塑的影响。来自HOMAGE临床试验的见解

2021-12-0920
OA